SCHEMBL692482

SCHEMBL692482

O=C1CCCCc2nc(NC(O)=S)sc21

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 11/20 0.59
RAB9A P51151 7/20 0.59
NPC1 O15118 6/20 0.59
SMN1; SMN2 Q16637 5/20 0.59
POLB P06746 2/20 0.59
TP53 P04637 1/20 0.59
MAPK1 P28482 2/20 0.46
GRM5 P41594 1/20 0.43
MEN1 O00255 1/20 0.40
KMT2A Q03164 1/20 0.40
TSHR P16473 1/20 0.40
PIK3CD O00329 1/20 0.38
PIK3CA P42336 1/20 0.38
PIK3CB P42338 1/20 0.38
PIK3CG P48736 1/20 0.38
L3MBTL1 Q9Y468 2/20 0.38
LMNA P02545 2/20 0.38
KDM4E B2RXH2 2/20 0.36
HPGD P15428 1/20 0.36
HTT P42858 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3277212 0.97 ALDH1A1 (0.63) ALDH1A1RAB9ANPC1SMN1; SMN2POLB
SCHEMBL3273226 0.83 ALDH1A1 (0.68) ALDH1A1RAB9ANPC1SMN1; SMN2POLB
SCHEMBL1771243 0.81 ALDH1A1 (0.59) ALDH1A1RAB9ANPC1SMN1; SMN2POLB
SCHEMBL691361 0.79 TSHR (0.67) ALDH1A1RAB9ANPC1SMN1; SMN2POLB
SCHEMBL3277209 0.78 ALDH1A1 (0.63) ALDH1A1RAB9ANPC1SMN1; SMN2POLB
SCHEMBL172155 0.78 ALDH1A1 (0.63) ALDH1A1RAB9ANPC1SMN1; SMN2POLB
SCHEMBL692419 0.78 ALDH1A1 (0.55) ALDH1A1RAB9ANPC1SMN1; SMN2POLB
SCHEMBL1118025 0.76 TSHR (0.62) ALDH1A1RAB9ANPC1SMN1; SMN2POLB
Bromide SCHEMBL7480303 0.76 ALDH1A1 (0.56) ALDH1A1RAB9ANPC1SMN1; SMN2POLB
SCHEMBL1118053 0.75 ALDH1A1 (0.59) ALDH1A1RAB9ANPC1SMN1; SMN2POLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2421871-A1 THIA-TRIAZA-CYCLOPENTAZULENES AS PI3-KINASES INHIBITORS FOR THE TREATMENT OF CANCER Boehringer Ingelheim International GmbH (DE) 2012-02-29 EP disclosed
WO-2010122071-A1 THIA-TRIAZA-CYCLOPENTAZULENES AS PI3-KINASES INHIBITORS FOR THE TREATMENT OF CANCER BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2010-10-28 WO disclosed